Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study
Affiliations
- PMID: 11927504
Item in Clipboard
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study
Cancer Epidemiol Biomarkers Prev.
2002 Apr.
No abstract available
Similar articles
-
Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.Urol Oncol. 2005 Jul-Aug;23(4):246-53. doi: 10.1016/j.urolonc.2004.12.014. Urol Oncol. 2005. PMID: 16018939
-
Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.Cancer Genet Cytogenet. 2009 Mar;189(2):71-6. doi: 10.1016/j.cancergencyto.2008.09.012. Cancer Genet Cytogenet. 2009. PMID: 19215786
-
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.Eur Urol. 2007 Oct;52(4):1082-7. doi: 10.1016/j.eururo.2007.04.008. Epub 2007 Apr 13. Eur Urol. 2007. PMID: 17448593
-
Cytogenetics and molecular genetics of cancer of the prostate.Am J Med Genet. 2002 Oct 30;115(3):150-6. doi: 10.1002/ajmg.10694. Am J Med Genet. 2002. PMID: 12407695 Review.
-
Prostate cancer: 3. Individual risk factors.CMAJ. 1998 Oct 6;159(7):807-13. CMAJ. 1998. PMID: 9805030 Free PMC article. Review. No abstract available.
Cited by
-
Genetic variation: effect on prostate cancer.Biochim Biophys Acta. 2014 Dec;1846(2):446-56. doi: 10.1016/j.bbcan.2014.08.007. Epub 2014 Sep 6. Biochim Biophys Acta. 2014. PMID: 25199985 Free PMC article. Review.
-
Genetic alterations in prostate cancer.Curr Urol Rep. 2004 Jun;5(3):157-65. doi: 10.1007/s11934-004-0032-8. Curr Urol Rep. 2004. PMID: 15161563 Review.
-
Genetic polymorphisms and prostate cancer risk.World J Urol. 2004 Feb;21(6):414-23. doi: 10.1007/s00345-003-0378-4. Epub 2003 Nov 26. World J Urol. 2004. PMID: 14648103 Review.
-
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2557-65. doi: 10.1158/1055-9965.EPI-07-0542. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18086758 Free PMC article.
-
SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.Prostate. 2007 Nov 1;67(15):1654-63. doi: 10.1002/pros.20625. Prostate. 2007. PMID: 17823934 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Molecular Biology Databases